Home
About
Technology
Products
Services
News
Information
Contact
Latest News
Horizon Discovery Signs Technology Evaluation Agreement Relating to X-MAN Cell-Lines with Array BioPharma »
X-MAN: Q4 Special
12 month evaluation of 3, 5, 7, 9, 12 isogenic cell-line pairs. Up to 50% discount from list price of single lines for POs received by 20/12/09 »
New Publications
Synthetic lethal targeting of phosphatase and tensin homolog (PTEN) mutant cells with poly (ADP-ribose) polymerase (PARP) inhibitors »
